Similar results were obtained from ccRCC patient samples with VHL loss-of-function mutations, where a positive correlation was seen between PD-L1 expression, HIF-2a expression and VHL mutations. The gene discussed is EPAS1; the disease is nonpapillary renal cell carcinoma.